13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-05, with 37 holding rows worth $226,505,046.
- Accession
- 0001381843-25-000004
- Filer
- CIK 1381843
- Filed
- 2025-05-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 37 entries on the cover page, a total value of $226,505,046 stated on the cover page (in dollars after the unit check, H1), rows summing to $226,505,046 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 34,602 | $28,578,138 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 89,227 | $18,694,841 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 25,782 | $13,503,323 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 132,273 | $13,343,700 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 127,679 | $11,460,467 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 22,857 | $11,373,643 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 22,808 | $11,057,775 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 31,553 | $8,774,574 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 76,998 | $8,627,626 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 22,998 | $8,561,006 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 75,881 | $8,392,439 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 26,577 | $8,280,064 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 15,345 | $7,599,918 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 214,778 | $7,091,970 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 25,141 | $6,842,626 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 151,348 | $5,232,100 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 59,696 | $4,326,766 | dollars as filed | |
| UFP TECHNOLOGIES INC | 902673102 | COM | 21,259 | $4,288,153 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 23,491 | $4,235,427 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 27,688 | $3,814,576 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 77,263 | $3,480,698 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 45,841 | $3,130,482 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 91,301 | $3,030,280 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 44,171 | $2,897,618 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 37,098 | $2,650,652 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 107,783 | $2,206,318 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 34,690 | $2,202,468 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 20,547 | $2,150,860 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 105,077 | $2,026,935 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 54,961 | $1,943,421 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 119,833 | $1,561,424 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 35,292 | $1,485,440 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 46,808 | $1,263,816 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 390,000 | $877,500 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 479,644 | $743,448 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 98,304 | $521,994 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 182,354 | $252,560 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-25-000004 | this filing | 2025-05-05 | acceptance time not in the bulk data set |